US Patent 11066483 Cytotoxicity-inducing therapeutic agent

Patent

US Patent 10435458 Antibody constant region variants with reduced Fcgammar binding

US Patent 10934344 Methods of modifying antibodies for purification of bispecific antibodies

US Patent 10759870 Multispecific antigen-binding molecules having blood coagulation factor VIII (FVIII) cofactor function-substituting activity and pharmaceutical formulations containing such a molecule as an active ingredient

US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38

US Patent 11492407 Bispecific checkpoint inhibitor antibodies

US Patent 11505605 T cell-redirected antigen-binding molecule for cells having immunosuppression function

US Patent 11591401 Anti-CD28 compositions

US Patent 11649262 Method for promoting efficiency of purification of Fc region-containing polypeptide

US Patent 11649293 Method for enhancing humoral immune response

US Patent 11673972 Heterodimeric antibodies that bind CD3 and tumor antigens

US Patent 11851476 Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain

US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3

US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3

United States Patent and Trademark Office

Lynn A Bristol